Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Bone Oncology|October 19, 2020
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcomaParunya Chaiyawat, Nutnicha Sirikaew, Piyaporn Budprom, et al.
Translational Oncology|September 8, 2017
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in OsteosarcomaParunya Chaiyawat, Jeerawan Klangjorhor, Jongkolnee Settakorn, et al.
Cancers|July 27, 2022
Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic ReviewSanthasiri Orrapin, Sasimol Udomruk, Worakitti Lapisatepun, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern ThailandDumnoensun Pruksakorn, Areerak Phanphaisarn, Donsuk Pongnikorn, et al.
International Journal of Molecular Sciences|August 12, 2023
Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in CancerSanthasiri Orrapin, Patcharawadee Thongkumkoon, Sasimol Udomruk, et al.
Scientific Reports|May 26, 2021
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcomaParunya Chaiyawat, Areerak Phanphaisarn, Nutnicha Sirikaew, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2020
In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patientsJeerawan Klangjorhor, Areerak Phanphaisarn, Pimpisa Teeyakasem, et al.
Gene|December 13, 2022
Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposingRawikant Kamolphiwong, Kanyanatt Kanokwiroon, Weerinrada Wongrin, et al.
Glycoconjugate Journal|February 20, 2021
Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancerChris Verathamjamras, Tanin-Ek Sriwitool, Pukkavadee Netsirisawan, et al.
World Journal of Surgical Oncology|November 4, 2017
Safety and efficacy of intralesional steroid injection for aggressive fibromatosisDumnoensun Pruksakorn, Sratwadee Lorsomradee, Areerak Phanphaisarn, et al.
Pageof 5